skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 416  for All Library Resources

Results 1 2 3 4 5 next page
Refined by: Journal Title: Reactions Weekly remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Immune-globulin: Lack of efficacy: case report
Material Type:
Article
Add to My Research

Immune-globulin: Lack of efficacy: case report

Reactions weekly, 2023-05 (1958), p.272-272

Copyright Springer Nature B.V. May 27, 2023 ;ISSN: 0114-9954 ;EISSN: 1179-2051

Full text available

2
Multiple drugs: Lack of efficacy: case report
Material Type:
Article
Add to My Research

Multiple drugs: Lack of efficacy: case report

Reactions weekly, 2023-05 (1958), p.364-364

Copyright Springer Nature B.V. May 27, 2023 ;ISSN: 0114-9954 ;EISSN: 1179-2051

Full text available

3
Azacitidine/durvalumab: Various toxicities: case report
Material Type:
Article
Add to My Research

Azacitidine/durvalumab: Various toxicities: case report

Reactions weekly, 2023-05 (1957), p.76-76

Copyright Springer Nature B.V. May 20, 2023 ;ISSN: 0114-9954 ;EISSN: 1179-2051

Full text available

4
Ampicillin/sulbactam Lack of efficacy: case report
Material Type:
Article
Add to My Research

Ampicillin/sulbactam Lack of efficacy: case report

Reactions weekly, 2023-02 (1944), p.54-54

Copyright Springer Nature B.V. Feb 18, 2023 ;ISSN: 0114-9954 ;EISSN: 1179-2051

Full text available

5
Nivolumab/pembrolizumab/prednisone: Guillain-Barre-syndrome, Miller Fisher syndrome and lack of efficacy: 3 case reports
Material Type:
Article
Add to My Research

Nivolumab/pembrolizumab/prednisone: Guillain-Barre-syndrome, Miller Fisher syndrome and lack of efficacy: 3 case reports

Reactions weekly, 2022-11 (1933), p.353-353

Copyright Springer Nature B.V. Nov 19, 2022 ;ISSN: 0114-9954 ;EISSN: 1179-2051

Full text available

6
Albendazole: Lack of efficacy: case report
Material Type:
Article
Add to My Research

Albendazole: Lack of efficacy: case report

Reactions weekly, 2022-10 (1930), p.22-22

Copyright Springer Nature B.V. Oct 29, 2022 ;ISSN: 0114-9954 ;EISSN: 1179-2051

Full text available

7
AZD-1222: Guillain-Barre-syndrome: case report
Material Type:
Article
Add to My Research

AZD-1222: Guillain-Barre-syndrome: case report

Reactions weekly, 2022-10 (1926), p.113-113

Copyright Springer Nature B.V. Oct 1, 2022 ;ISSN: 0114-9954 ;EISSN: 1179-2051

Full text available

8
Immune-globulin/nitrous-oxide: Myeloneuropathy following drug abuse and lack of efficacy : case report
Material Type:
Article
Add to My Research

Immune-globulin/nitrous-oxide: Myeloneuropathy following drug abuse and lack of efficacy : case report

Reactions weekly, 2022-09 (1922), p.318-318

Copyright Springer Nature B.V. Sep 3, 2022 ;ISSN: 0114-9954 ;EISSN: 1179-2051

Full text available

9
Immune-globulin: Lack of efficacy: case report
Material Type:
Article
Add to My Research

Immune-globulin: Lack of efficacy: case report

Reactions weekly, 2022-07 (1916), p.226-226

Copyright Springer Nature B.V. Jul 23, 2022 ;ISSN: 0114-9954 ;EISSN: 1179-2051

Full text available

10
Eculizumab: Diabetes insipidus: case report
Material Type:
Article
Add to My Research

Eculizumab: Diabetes insipidus: case report

Reactions weekly, 2022-06 (1911), p.194-194

Copyright Springer Nature B.V. Jun 18, 2022 ;ISSN: 0114-9954 ;EISSN: 1179-2051

Full text available

11
Bortezomib: Guillain-Barre-syndrome: case report
Material Type:
Article
Add to My Research

Bortezomib: Guillain-Barre-syndrome: case report

Reactions weekly, 2022-04 (1901), p.136-136

Copyright Springer Nature B.V. Apr 9, 2022 ;ISSN: 0114-9954 ;EISSN: 1179-2051

Full text available

12
AZD-1222: Guillain-Barre syndrome: case report
Material Type:
Article
Add to My Research

AZD-1222: Guillain-Barre syndrome: case report

Reactions weekly, 2022-01 (1889), p.74-74

Copyright Springer Nature B.V. Jan 15, 2022 ;ISSN: 0114-9954 ;EISSN: 1179-2051

Full text available

13
BCG: Guillain-Barre Syndrome: case report
Material Type:
Article
Add to My Research

BCG: Guillain-Barre Syndrome: case report

Reactions weekly, 2022-01 (1888), p.98-98

Copyright Springer Nature B.V. Jan 8, 2022 ;ISSN: 0114-9954 ;EISSN: 1179-2051

Full text available

14
Tolvaptan: No response: case report
Material Type:
Article
Add to My Research

Tolvaptan: No response: case report

Reactions weekly, 2022-01 (1887), p.646-646

Copyright Springer Nature B.V. Jan 1, 2022 ;ISSN: 0114-9954 ;EISSN: 1179-2051

Full text available

15
Levetiracetam: Lack of efficacy: case report
Material Type:
Article
Add to My Research

Levetiracetam: Lack of efficacy: case report

Reactions weekly, 2023-06 (1959), p.366-366

Copyright Springer Nature B.V. Jun 3, 2023 ;ISSN: 0114-9954 ;EISSN: 1179-2051

Full text available

16
Multiple drugs Lack of efficacy: case report2
Material Type:
Article
Add to My Research

Multiple drugs Lack of efficacy: case report2

Reactions weekly, 2021-11 (1880), p.272-272

Copyright Springer Nature B.V. Nov 6, 2021 ;ISSN: 0114-9954 ;EISSN: 1179-2051

Full text available

17
Azathioprine/immune-globulin/prednisone: Lack of efficacy: case report
Material Type:
Article
Add to My Research

Azathioprine/immune-globulin/prednisone: Lack of efficacy: case report

Reactions weekly, 2021-10 (1878), p.99-99

Copyright Springer Nature B.V. Oct 23, 2021 ;ISSN: 0114-9954 ;EISSN: 1179-2051

Full text available

18
Nelarabine: Guillain-Barre syndrome: case report
Material Type:
Article
Add to My Research

Nelarabine: Guillain-Barre syndrome: case report

Reactions weekly, 2021-10 (1876), p.258-258

Copyright Springer Nature B.V. Oct 9, 2021 ;ISSN: 0114-9954 ;EISSN: 1179-2051

Full text available

19
Streptokinase Guillain-Barre syndrome: case report
Material Type:
Article
Add to My Research

Streptokinase Guillain-Barre syndrome: case report

Reactions weekly, 2023-03 (1947), p.363-363

Copyright Springer Nature B.V. Mar 11, 2023 ;ISSN: 0114-9954 ;EISSN: 1179-2051

Full text available

20
Immune-globulin Lack of efficacy: case report
Material Type:
Article
Add to My Research

Immune-globulin Lack of efficacy: case report

Reactions weekly, 2023-02 (1944), p.305-305

Copyright Springer Nature B.V. Feb 18, 2023 ;ISSN: 0114-9954 ;EISSN: 1179-2051

Full text available

Results 1 - 20 of 416  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Refine My Results

Creation Date 

From To
  1. Before 2011  (9)
  2. 2011 To 2016  (8)
  3. 2017 To 2018  (54)
  4. 2019 To 2021  (174)
  5. After 2021  (172)
  6. More options open sub menu

Searching Remote Databases, Please Wait